Company Overview and News


Add ENDP
to your dashboard

Headline News

Endo International Is Still Not Cheap Enough

9h seekingalpha
Being a deep value investor I was initially attracted me to Endo (ENDP), particularly since I'm already heavily invested in the generic space. However, upon a closer appraisal of Endo's prospects, I have come to believe that its stock is actually overvalued, as it carries too much debt relative to its servicing capacity, in addition to it facing strong headwinds in operationally. (20-0)

Endo (ENDP) Loses 35% in a Year: Can It Turn Around in 2018?

2018-01-16 zacks
Shares of Endo International plc (ENDP - Free Report) have tumbled 35.4% over a year against the industry’s gain of 7.1%. (57-0)

FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International plc (ENDP) & Lead Plaintiff Deadline - January 16, 2018

2018-01-15 accesswire
NEW YORK, NY / ACCESSWIRE / January 15, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) securities and certain of its officers, on behalf of a class who purchased Endo between September 28, 2015, and February 28, 2017, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www. (22-0)

Endo (ENDP) Gets Subpoena From Florida for Opioid Misuse

2018-01-12 zacks
Endo International plc (ENDP - Free Report) announced that its subsidiary, Endo Pharmaceuticals Inc. (EPI), received a grand jury subpoena from the United States Attorney's Office for the Southern District of Florida seeking documents and information relating to products containing opioid painkiller oxymorphone. (61-0)

Judge seeking settlement of opioid lawsuits reaches out to states: Ohio - Channel NewsAsia

2018-01-11 channelnewsasia
REUTERS: A federal judge pushing for a quick settlement of lawsuits against opioid manufacturers and distributors by U.S. cities and counties is seeking to meet with states that are separately suing and probing the companies, Ohio's attorney general said on Thursday. (272-0)

Endo gets subpoena for drugs containing opioid painkiller - Channel NewsAsia

2018-01-11 channelnewsasia
REUTERS: Endo International Plc said on Thursday its unit got a subpoena seeking documents and information related to its drugs that contain the opioid painkiller, oxymorphone. (22-0)

Endo gets subpoena for drugs containing opioid painkiller

2018-01-11 reuters
(Reuters) - Endo International Plc said on Thursday its unit got a subpoena seeking documents and information related to its drugs that contain the opioid painkiller, oxymorphone. (22-0)

BRIEF-Endo Comments On U.S. Attorney's Office Grand Jury Subpoena Relating To Products Containing Oxymorphone

2018-01-11 reuters
* ENDO COMMENTS ON UNITED STATES ATTORNEY‘S OFFICE GRAND JURY SUBPOENA RELATING TO PRODUCTS CONTAINING OXYMORPHONE (22-0)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP

2018-01-11 accesswire
NEW YORK, NY / ACCESSWIRE / January 10, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. The class action, filed in United States District Court, for the Eastern District of Pennsylvania, and docketed under 17-cv-05114, is on behalf of a class consisting of investors who purchased or otherwise acquired Endo securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934. (22-0)

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International plc (ENDP) & Lead Plaintiff Deadline - January 16, 2018

2018-01-10 accesswire
NEW YORK, NY / ACCESSWIRE / January 10, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) securities and certain of its officers, on behalf of a class who purchased Endo between September 28, 2015, and February 28, 2017, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www. (22-0)

3 Biotechs For The January Effect

2018-01-03 seekingalpha
In my view, three biotech microcaps may yield among the best risk/reward scenarios for investors today. (182-3)

Sanders Morris Harris Inc. - All Holdings - 13F 13D 13G Filings - Fintel.io

2018-01-02 fintel.io
Sanders Morris Harris Inc. has disclosed 142 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 234,443,000 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Sanders Morris Harris Inc.'s top holdings are Main Street Capital Corp. (NYSE:MAIN) , Enterprise Products Partners L.P. (NYSE:EPD) , Eclipse Resources Corp. (NYSE:ECR) , The Joint Corp. (126-1)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP

2017-12-31 accesswire
NEW YORK, NY / ACCESSWIRE / December 30, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) and certain of its officers. The class action, filed in United States District Court, for the Eastern District of Pennsylvania, and docketed under 17-cv-05114, is on behalf of a class consisting of investors who purchased or otherwise acquired Endo securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934. (22-0)

CUSIP: G30401106